0001562180-17-003959.txt : 20171219
0001562180-17-003959.hdr.sgml : 20171219
20171219210806
ACCESSION NUMBER: 0001562180-17-003959
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20171216
FILED AS OF DATE: 20171219
DATE AS OF CHANGE: 20171219
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Oltmans Curtis Gale
CENTRAL INDEX KEY: 0001714982
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-16633
FILM NUMBER: 171265583
MAIL ADDRESS:
STREET 1: C/O ARRAY BIOPHARMA INC.
STREET 2: 3200 WALNUT ST.
CITY: BOULDER
STATE: CO
ZIP: 80301
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ARRAY BIOPHARMA INC
CENTRAL INDEX KEY: 0001100412
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 841460811
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 3200 WALNUT STREET
CITY: BOULDER
STATE: CO
ZIP: 80301
BUSINESS PHONE: 3033816600
MAIL ADDRESS:
STREET 1: 3200 WALNUT STREET
CITY: BOULDER
STATE: CO
ZIP: 80301
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2017-12-16
false
0001100412
ARRAY BIOPHARMA INC
ARRY
0001714982
Oltmans Curtis Gale
C/O ARRAY BIOPHARMA, 3200 WALNUT ST.
BOULDER
CO
80301
false
true
false
false
General Counsel
Restricted Stock Units
0.00
2017-12-16
4
A
false
28000.00
0.00
A
2021-12-17
Common Stock
28000.00
28000.00
D
Stock Option (Right to Buy)
10.92
2017-12-16
4
A
false
168000.00
0.00
A
2027-12-16
Common Stock
168000.00
168000.00
D
Consists of RSUs awarded to the reporting person for no additional cash consideration each of which represent a contingent right to receive one share of Array BioPharma Inc. common stock. The RSUs vest and will be settled in stock in four equal annual installments beginning on December 16, 2018.
The option vests in four equal annual installments beginning on December 16, 2018.
Curtis Oltmans
2017-12-19